Complement Therapeutics
Munich, DE · 4 known investors
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration. A University of Manchester spinout, it runs clinical and natural history studies in ophthalmology across the US and UK.
Founders & leadership
RH
MA
Muhammad Ali MemoninChief Medical Officer
Investors · 4
Competitors · 3
by search overlapInmune Bio7 shared keywordsINmune Bio is a clinical-stage biotechnology company developing immunotherapies, including XPro1595, aimed at treating neurodegenerative and psychiatric diseases through a biomarker-directed approach. The company works on translating inflammatory therapies into clinical treatments for neurologic and other diseases.
Cellular Origins7 shared keywordsCellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.
Resolution Therapeutics6 shared keywordsResolution Therapeutics develops Regenerative Macrophage Therapy, a cell therapy for patients with end-stage liver disease intended to help damaged livers recover and slow disease progression. Its EMERALD early-stage clinical trial is running in the UK and Spain.
Companies competing with Complement Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Complement Therapeutics do?
- Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration. A University of Manchester spinout, it runs clinical and natural history studies in ophthalmology across the US and UK.
- Who are Complement Therapeutics's investors?
- Complement Therapeutics's investors include Hadean Ventures, Seroba Life Sciences, BioGeneration Ventures, Cambridge Innovation Capital.
- Where is Complement Therapeutics headquartered?
- Complement Therapeutics is headquartered in Munich, DE.